These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 20578100

  • 1. Management of residual shunts after initial percutaneous patent foramen ovale closure: a single center experience with immediate and long-term follow-up.
    Diaz T, Cubeddu RJ, Rengifo-Moreno PA, Cruz-Gonzalez I, Solis-Martin J, Buonanno FS, Inglessis I, Palacios IF.
    Catheter Cardiovasc Interv; 2010 Jul 01; 76(1):145-50. PubMed ID: 20578100
    [Abstract] [Full Text] [Related]

  • 2. Residual shunting after percutaneous PFO closure: how to manage and how to close.
    Butera G, Sarabia JF, Saracino A, Chessa M, Piazza L, Carminati M.
    Catheter Cardiovasc Interv; 2013 Nov 15; 82(6):950-8. PubMed ID: 23804551
    [Abstract] [Full Text] [Related]

  • 3. Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.
    Taggart NW, Reeder GS, Lennon RJ, Slusser JP, Freund MA, Cabalka AK, Cetta F, Hagler DJ.
    Catheter Cardiovasc Interv; 2017 Jan 15; 89(1):124-133. PubMed ID: 27027873
    [Abstract] [Full Text] [Related]

  • 4. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S, Furlan AJ, Reisman M, Burke D, Vardi M, Wimmer NJ, Ling S, Chen X, Kent DM, Massaro J, Mauri L, CLOSURE I Investigators.
    JACC Cardiovasc Interv; 2014 Aug 15; 7(8):913-20. PubMed ID: 25147037
    [Abstract] [Full Text] [Related]

  • 5. Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study.
    Marchese N, Pacilli MA, Inchingolo V, Fanelli R, Loperfido F, Vigna C.
    EuroIntervention; 2013 Jul 15; 9(3):382-8. PubMed ID: 23872652
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Percutaneous patent foramen ovale closure using the Occlutech Figulla device: More than 1,300 patient-years of follow up.
    Snijder RJR, Renes LE, Suttorp MJ, Ten Berg JM, Post MC.
    Catheter Cardiovasc Interv; 2019 May 01; 93(6):1080-1084. PubMed ID: 30461175
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of different devices for transcatheter closure of patent foramen ovale assessed by serial transoesophageal echocardiography and rates of recurrent cerebrovascular events in a long-term follow-up.
    Luani B, Markovic S, Krumsdorf U, Rottbauer W, Wöhrle J.
    EuroIntervention; 2015 May 01; 11(1):85-91. PubMed ID: 25572024
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Determinants and clinical significance of persistent residual shunting in patients with percutaneous patent foramen ovale closure devices.
    Shafi NA, McKay RG, Kiernan FJ, Silverman IE, Ahlquist M, Silverman DI.
    Int J Cardiol; 2009 Nov 12; 137(3):314-6. PubMed ID: 19616327
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interventional closure of patent foramen ovale with Nit-occlud® device in prevention of recurrent neurologic events-Long-term results.
    Araszkiewicz A, Sławek S, Trojnarska O, Lesiak M, Grygier M.
    Catheter Cardiovasc Interv; 2018 Jul 12; 92(1):159-164. PubMed ID: 29068141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.